Root stock price forecast models factoring in the latest consumer demand trends predict continued upward movement, with Q4 2024 potential to hit $13. Find out about the key risks to this Alignment Healthcare narrative. A series of analyst upgrades and increased price target predictions have led to this boon in market capitalization. 100% of analysts tracked by MarketBeat gave ASTS a Buy rating, with an estimated 33% additional upside in the next year. In the latest root stock price forecast, dividend policy reviews—though minimal at present—indicate possibility of future shareholder returns. While not the main driver, combined with growth metrics, such potential could enhance the stock’s risk-reward profile substantially.
